Publication | Open Access

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study

Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaMedicineImmunologyImmune Checkpoint InhibitorPhase 1/2APharmacotherapyImmunotherapyOncologyRelapsed Non-hodgkin Lymphoma